Nocion Therapeutics is a clinical-stage biopharmaceutical company discovering and developing a novel class of biologically selective charged sodium channel (NaV) blockers designed to selectively silence overactive sensory neurons to relieve chronic cough, pain, itch, and inflammation. - View it on GitHub